Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more

  • Year: 2023
  • Scope: 10 Years
  • Region: Global
  • Pages: 577
  • Type: MedSuite

Product Description

Overall, the global interventional cardiology market was valued at $11 billion in 2022. This is expected to increase over the forecast period at a CAGR of 2.4% to reach $13 billion.

The full report suite on the global market for interventional cardiology includes the coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter and intravascular ultrasound (IVUS) catheter markets.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Interventional Cardiology Procedure Volumes
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Global Interventional Cardiology market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Global Interventional Cardiology market
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Interventional Cardiology Market Insights

Access to healthcare and overall hospital infrastructure in developing countries within Latin America and Asia-Pacific countries such as China and India have been increasing over the last decade. This has allowed for more of the global population to get interventional procedures completed as well as the expansion of the device market. Prices are expected to continue to decline over the forecast period, driven by the trend of consolidation in the market and bundling. Due to the number of competitors in the market, they often bundle together devices at a lower price in order to increase overall sales.

Interventional Cardiology Market Overview

Adoption of intravascular imaging technologies is not yet equal across the globe. North America and Asia Pacific continue to have the highest usage rate of the devices, while the rest of the globe maintain a slow but growing use of the technology.

Global Interventional Cardiology Market Share Insight

In 2022, the global interventional cardiology market share was controlled by three key competitors – Boston Scientific, Abbott, and Medtronic.

Top Global Interventional Cardiology Device Market

Boston Scientific was the leader of several segments, including coronary stents, balloon catheters and embolic protection devices. Boston Scientific’s wide range of devices and complementary products for interventional cardiology, combined with its international sales team, has allowed it to maintain its dominant position

Abbott led the interventional coronary guidewire and OCT catheter markets in Western Europe. The Xience™ drug-eluting stent is a popular CTO-indicated line of coronary stents in terms of units sold.

Medtronic has a presence in the coronary stent, coronary balloon catheter, interventional coronary catheter, diagnostic catheter and guidewire, Interventional Coronary catheter, Guidewire Market, Embolic Protection Device Market and Coronary Introducer Sheath Market. Medtronic performed in the interventional coronary catheter market, where it offered the Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced and Telescope™ product lines under its portfolio.

Report Geographic Coverage

Throughout this research series, iData Research has covered several regions in great detail. The regions covered are:

  • North America (United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Detailed Market Segmentation

While this MedSuite report contains all the Global Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

  • Coronary Stent Market – MedCore 
  • Coronary Balloon Catheter Market – MedCore
  • Interventional Coronary Catheter Market – MedCore 
  • Interventional Coronary Guidewire Market – MedCore
  • Coronary Embolic Protection Device Market – MedCore 
  • Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore 
  • Coronary Introducer Sheath Market – MedCore
  • Coronary Vascular Closure Device (VCD)  Market – MedCore
  • Diagnostic Coronary Catheter & Guidewire Market – MedCore
  • Intravascular Ultrasound (IVUS) Market – MedCore
  • Coronary Optical Coherency Tomography Catheter Market – MedCore

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America (United States and Canada)

Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)

Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)

Central & Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)

Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)

Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Base Year 2022
Forecast 2023-2029
Historical Data 2019-2022
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

  • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Table of Contents:
TABLE of CONTENTS
TABLE of CONTENTS i
List of Figures xii
List of Charts xxviii
executive summary 1
Global Interventional Cardiology Device Market Overview 1
Competitive Analysis 3
Market Trends 7
Market Developments 9
Procedures Included 11
Markets Included 12
Regions Included 13
Version History 15
research methodology 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
impact of covid-19 on THE global Interventional cardiology Market 30
2.1 Introduction 30
2.2 Regional Profiles 32
2.3 Analysis By Market Segment 34
2.3.1 Worst Case Scenario 34
2.3.2 Base Case Scenario 36
2.3.3 Best Case Scenario 38
Disease Overview 41
3.1 Basic Anatomy 41
3.2 Disease Treatment and Diagnostic 43
3.2.1 General Diagnostics 43
3.2.2 Coronary Artery Disease 43
3.2.3 Myocardial Infarction 44
3.2.4 Angina Pectoris 45
3.3 Patient Demographics 46
Product Assessment 48
4.1 Introduction 48
4.2 Product Portfolios 49
4.2.1 Coronary Stent Market 49
4.2.2 Coronary Balloon Catheter Market 51
4.2.3 Interventional Coronary Catheter Market 53
4.2.4 Interventional Coronary Guidewire Market 55
4.2.5 Coronary Embolic Protection Device Market 57
4.2.5.1 Saphenous Vein Grafts 57
4.2.5.2 Protection Mechanism 57
4.2.5.2.1 Filter Basket 57
4.2.5.2.2 Distal Balloon Occlusion 58
4.2.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market 59
4.2.7 Introducer Sheath Market 61
4.2.8 Coronary Vascular Closure Device Market 64
4.2.9 Diagnostic Coronary Catheter & Guidewire Market 66
4.2.10 Coronary Intravascular Ultrasound Market 68
4.2.11 Coronary Optical Coherence Tomography Market 70
4.3 Regulatory Issues and Recalls 72
4.3.1 Coronary Stent Market FDA Recalls 72
4.3.2 Coronary Balloon Catheter Market FDA Recalls 74
4.3.3 Interventional Coronary Catheter Market FDA Recalls 76
4.3.4 Interventional Coronary Guidewire Market FDA Recalls 79
4.3.5 Coronary Atherectomy and Intravascular Lithotripsy Device Market FDA Recalls 80
4.3.6 Coronary Introducer Sheath Market FDA Recalls 81
4.3.7 Coronary Vascular Closure Device Market FDA Recalls 85
4.3.8 Diagnostic Coronary Catheter & Guidewire Market FDA Recalls 86
4.3.9 Coronary Intravascular Ultrasound Market FDA Recalls 87
4.4 Clinical Trials 88
4.4.1 Coronary Stent Market Clinical Trials 89
4.4.2 Coronary Balloon Catheter Market Clinical Trials 95
4.4.3 Interventional Coronary Catheter Market Clinical Trials 99
4.4.4 Interventional Coronary Guidewire Market Clinical Trials 101
4.4.5 Coronary Embolic Protection Device Market Clinical Trials 102
4.4.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market Clinical Trials 104
4.4.7 Coronary Vascular Closure Device 106
4.4.8 Coronary Intravascular Ultrasound 112
4.4.9 Coronary Optical Coherence Tomography 116
Global Interventional cardiology Device Market Overview 118
5.1 Introduction 118
5.1.1 Population at Risk 118
5.2 Market Overview & Trend Analysis 120
5.2.1 By Segment 120
5.2.2 By Region 126
5.3 Drivers and Limiters 130
5.3.1 Market Drivers 130
5.3.2 Market Limiters 132
5.4 Competitive Market Share Analysis 134
5.5 Mergers and Acquisitions 142
5.6 Company Profiles 144
5.6.1 Abbott 144
5.6.2 Asahi Intecc 145
5.6.3 Boston Scientific 146
5.6.4 Cook Medical 147
5.6.5 Cordis 148
5.6.6 Medtronic 149
5.6.7 Penumbra 150
5.6.8 Philips 151
5.6.9 Teleflex 152
5.6.10 Terumo 153
5.7 SWOT Analysis 154
5.7.1 Abbott 155
5.7.2 Asahi Intecc 157
5.7.3 Boston Scientific 158
5.7.4 Cordis 159
5.7.5 Cook Medical 160
5.7.6 Medtronic 161
5.7.7 Penumbra 162
5.7.8 Philips 163
5.7.9 Teleflex 164
5.7.10 Terumo 165
Coronary Stent Market 166
6.1 Executive Summary 166
6.1.1 Global Coronary Stent Market Overview 166
6.1.2 Competitive Analysis 168
6.1.3 Procedures Included 169
6.1.4 Markets Included 170
6.1.5 Regions Included 171
6.2 Introduction 173
6.3 Procedure Numbers 175
6.4 Market Overview 189
6.4.1 By Segment 190
6.4.2 By Region 192
6.5 Market Analysis and Forecast 194
6.5.1 Total Coronary Stent Market 194
6.5.2 Bare-Metal Stent Market 198
6.5.3 Drug-Eluting Stent Market 202
6.6 Drivers and Limiters 206
6.6.1 Market Drivers 206
6.6.2 Market Limiters 207
6.7 Competitive Market Share Analysis 209
Coronary Balloon Catheter Market 213
7.1 Executive Summary 213
7.1.1 Global Coronary Balloon Catheter Market Overview 213
7.1.2 Competitive Analysis 216
7.1.3 Procedures Included 217
7.1.4 Markets Included 218
7.1.5 Regions Included 219
7.2 Introduction 221
7.3 Procedure Numbers 223
7.4 Market Overview 237
7.4.1 By Segment 238
7.4.2 By Region 240
7.5 Market Analysis and Forecast 242
7.5.1 Total Coronary Balloon Catheter Market 242
7.5.2 PTCA Balloon Catheter Market 246
7.5.3 Specialty Balloon Catheter Market 250
7.6 Drivers and Limiters 254
7.6.1 Market Drivers 254
7.6.2 Market Limiters 254
7.7 Competitive Market Share Analysis 256
interventional coronary catheter Market 260
8.1 Executive Summary 260
8.1.1 Global Interventional Coronary Catheter Market Overview 260
8.1.2 Competitive Analysis 262
8.1.3 Procedures Included 263
8.1.4 Regions Included 264
8.2 Introduction 266
8.3 Procedure Numbers 267
8.4 Market Analysis and Forecast 281
8.5 Drivers and Limiters 285
8.5.1 Market Drivers 285
8.5.2 Market Limiters 285
8.6 Competitive Market Share Analysis 287
Interventional Coronary guidewire Market 291
9.1 Executive Summary 291
9.1.1 Global Interventional Coronary Guidewire Market Overview 291
9.1.2 Competitive Analysis 293
9.1.3 Procedures Included 294
9.1.4 Regions Included 295
9.2 Introduction 297
9.3 Procedure Numbers 298
9.4 Market Analysis and Forecast 312
9.5 Drivers and Limiters 316
9.5.1 Market Drivers 316
9.5.2 Market Limiters 317
9.6 Competitive Market Share Analysis 318
Coronary embolic protection device Market 322
10.1 Executive Summary 322
10.1.1 Global Coronary Embolic Protection Device Market Overview 322
10.1.2 Competitive Analysis 325
10.1.3 Regions Included 326
10.2 Introduction 328
10.2.1 Protection Mechanism 328
10.2.1.1 Filter Basket 328
10.2.1.2 Distal Balloon Occlusion 328
10.3 Market Analysis and Forecast 330
10.4 Drivers and Limiters 334
10.4.1 Market Drivers 334
10.4.2 Market Limiters 335
10.5 Competitive Market Share Analysis 336
Atherectomy and Intravascular Lithotripsy Device Market 339
11.1 Executive Summary 339
11.1.1 Global Atherectomy and Intravascular Lithotripsy Device Market Overview 339
11.1.2 Competitive Analysis 342
11.1.3 Procedures Included 343
11.1.4 Regions Included 344
11.2 Introduction 346
11.3 Procedure Numbers 347
11.4 Market Analysis and Forecast 361
11.5 Drivers and Limiters 365
11.5.1 Market Drivers 365
11.5.2 Market Limiters 366
11.6 Competitive Market Share Analysis 367
Coronary Introducer Sheath Market 370
12.1 Executive Summary 370
12.1.1 Global Coronary Introducer Sheath Market Overview 370
12.1.2 Competitive Analysis 373
12.1.3 Procedures Included 374
12.1.4 Regions Included 375
12.2 Introduction 377
12.2.1 Introducer Sheaths 377
12.2.2 Micro-Introducers 377
12.2.3 Catheter Insertion Approaches 378
12.2.3.1 Femoral Approach 378
12.2.3.2 Radial/Brachial Approach 378
12.3 Procedure Numbers 379
12.4 Market Analysis and Forecast 393
12.5 Drivers and Limiters 397
12.5.1 Market Drivers 397
12.5.2 Market Limiters 397
12.6 Competitive Market Share Analysis 399
Coronary Vascular Closure Device Market 404
13.1 Executive Summary 404
13.1.1 Global Coronary Vascular Closure Device Market Overview 404
13.1.2 Competitive Analysis 406
13.1.3 Procedures Included 407
13.1.4 Markets Included 408
13.1.5 Regions Included 409
13.2 Introduction 411
13.2.1 Intravascular and Extravascular Devices 411
13.3 Procedure Numbers 412
13.4 Market Overview 426
13.4.1 By Segment 427
13.4.2 By Region 429
13.5 Market Analysis and Forecast 431
13.5.1 Total Coronary Vascular Closure Device Market 431
13.5.2 Invasive VCD Market 436
13.5.3 Non-Invasive VCD Market 440
13.6 Drivers and Limiters 444
13.6.1 Market Drivers 444
13.6.2 Market Limiters 445
13.7 Competitive Market Share Analysis 446
Diagnostic Catheter and Guidewire Market 450
14.1 Executive Summary 450
14.1.1 Global Diagnostic Catheter and Guidewire Market Overview 450
14.1.2 Competitive Analysis 453
14.1.3 Procedures Included 454
14.1.4 Markets Included 455
14.1.5 Regions Included 456
14.2 Introduction 458
14.3 Procedure Numbers 459
14.3.1 Total Procedures 459
14.3.2 Angiography Procedures 460
14.3.3 FFR Guidewire Procedures 474
14.4 Market Overview 488
14.4.1 By Segment 489
14.4.2 By Region 491
14.5 Market Analysis and Forecast 493
14.5.1 Total Diagnostic Catheter and Guidewire Market 493
14.5.2 Interventional Diagnostic Catheter Market 497
14.5.3 Interventional Diagnostic Guidewire Market 501
14.5.4 FFR Guidewire Market 505
14.6 Drivers and Limiters 509
14.6.1 Market Drivers 509
14.6.2 Market Limiters 509
14.7 Competitive Market Share Analysis 511
Optical Coherence Tomography Catheter Market 516
15.1 Executive Summary 516
15.1.1 Global Optical Coherence Tomography Catheter Market Overview 516
15.1.2 Competitive Analysis 518
15.1.3 Procedures Included 519
15.1.4 Regions Included 520
15.2 Introduction 522
15.2.1 OCT Applications 523
15.3 Procedure Numbers 524
15.4 Market Analysis and Forecast 538
15.5 Drivers and Limiters 542
15.5.1 Market Drivers 542
15.5.2 Market Limiters 543
15.6 Competitive Market Share Analysis 544
Intravascular Ultrasound Catheter Market 547
16.1 Executive Summary 547
16.1.1 Global Intravascular Ultrasound Catheter Market Overview 547
16.1.2 Competitive Analysis 549
16.1.3 Procedures Included 550
16.1.4 Regions Included 551
16.2 Introduction 553
16.2.1 Pre-Stenting Applications 553
16.2.2 Post-Stenting Applications 553
16.3 Procedure Numbers 554
16.4 Market Analysis and Forecast 568
16.5 Drivers and Limiters 572
16.5.1 Market Drivers 572
16.5.2 Market Limiters 573
16.6 Competitive Market Share Analysis 574
Abbreviations 577
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
 Abbott  Kardia
 Acrostak  Kimal
 Advanced Vascular Dynamics  Kojima Medical
 Alvimedica  Kossel Medical
 AndraTec  Lepu
 AngioDynamics  MedAlliance
 Argon Medical  Medinol
 Asahi Intecc  Medtronic
 Avinger  Meril Life Sciences
 B. Braun  Merit Medical
 Balton Medical  Morris Innovative
 Barty Medical  Nipro
 Baylis Medical  Opsens Medical
 Becton Dickinson  OrbusNeich
 Biolife  Oscor
 Biosensors  PediaVascular
 Biotronik  Philips
 Bolton Medical  Reflow Medical
 Boston Scientific  Rontis
 Cardionovum  SCW Medicath
 Cardiovascular Systems, Inc.  Semler Technologies
 Cardiva Medical  Shenzhen MicroApproach Medical Technology
 CeloNova BioSciences  Shenzhen X-Way Medical Technology
 Conavi  ShockWave Medical
 Contego Medical  SMT
 Cook Medical  Stentys
 Cordis  Teleflex
 DISA Medinotec  Terumo
 Elixir Medical Corporation  Tricol Biomedical
 Eucatech  KAI Medical
 Galt Medical  TZ Medical
 Hexacath  Vascular Perspectives
 IMDS  Vasorum
 InnoTherapy  WEGO
 Innovative Cardiovascular Solutions LLC  Wellinq
 iVascular  Z-Medica
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Chart List:
List of Charts
Chart 1‑1: Interventional Cardiology Market by Segment, Global, 2022 – 2029 2
Chart 1‑2: Interventional Cardiology Procedures, Global, 2022 & 2029 2
Chart 2‑1: Multi-Scenario Interventional Cardiology Market Forecast, Global, 2019 – 2029 (US$M) 40
Chart 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 125
Chart 5‑2: Interventional Cardiology Market by Region, Global, 2019 – 2029 129
Chart 5‑3: Leading Competitors, Interventional Cardiology Market, Global, 2022 141
Chart 6‑1: Coronary Stent Market, Global, 2022 & 2029 167
Chart 6‑2: Angioplasty/PCI Procedures, Global, 2022 167
Chart 6‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 177
Chart 6‑4: Coronary Stent Market by Segment, Global, 2019 – 2022 191
Chart 6‑5: Coronary Stent Market by Region, Global, 2019 – 2029 193
Chart 6‑6: Leading Competitors, Coronary Stent Market, Global, 2022 212
Chart 7‑1: Coronary Balloon Catheter Market, Global, 2022 & 2029 215
Chart 7‑2: Angioplasty/PCI Procedures, Global, 2022 215
Chart 7‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 225
Chart 7‑4: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 239
Chart 7‑5: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 241
Chart 7‑6: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 259
Chart 8‑1: Interventional Coronary Catheter Market, Global, 2022 & 2029 261
Chart 8‑2: Angioplasty/PCI Procedures, Global, 2022 261
Chart 8‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 269
Chart 8‑4: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 290
Chart 9‑1: Interventional Coronary Guidewire Market, Global, 2022 & 2029 292
Chart 9‑2: Angioplasty/PCI Procedures, Global, 2022 292
Chart 9‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 300
Chart 9‑4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 321
Chart 10‑1: Coronary Embolic Protection Device Market, Global, 2022 & 2029 324
Chart 10‑2: Coronary Embolic Protection Procedures, Global, 2022 324
Chart 10‑3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 338
Chart 11‑1: Atherectomy and IVL Device Market, Global, 2022 & 2029 341
Chart 11‑2: Atherectomy and IVL Procedures, Global, 2022 341
Chart 11‑3: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 349
Chart 11‑4: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 369
Chart 12‑1: Coronary Introducer Sheath Market, Global, 2022 & 2029 372
Chart 12‑2: Coronary Introducer Sheath Procedures, Global, 2022 372
Chart 12‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 381
Chart 12‑4: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 403
Chart 13‑1: Coronary Vascular Closure Device Market, Global, 2022 & 2029 405
Chart 13‑2: Coronary Vascular Closure Device Procedures, Global, 2022 405
Chart 13‑3: Catheterization Procedures by Region, Global, 2019 – 2029 414
Chart 13‑4: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029 428
Chart 13‑5: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 430
Chart 13‑6: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 449
Chart 14‑1: Diagnostic Catheter and Guidewire Market, Global, 2022 & 2029 452
Chart 14‑2: Diagnostic Catheter and Guidewire Procedures, Global, 2022 452
Chart 14‑3: Angiography Procedures by Region, Global, 2019 – 2029 462
Chart 14‑4: FFR Guidewire Procedures by Region, Global, 2019 – 2029 476
Chart 14‑5: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 490
Chart 14‑6: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 492
Chart 14‑7: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 515
Chart 15‑1: OCT Catheter Market, Global, 2022 & 2029 517
Chart 15‑2: OCT Catheter Procedures, Global, 2022 517
Chart 15‑3: OCT Procedures by Region, Global, 2019 – 2029 526
Chart 15‑4: Leading Competitors, OCT Catheter Market, Global, 2022 546
Chart 16‑1: IVUS Catheter Market, Global, 2022 & 2029 548
Chart 16‑2: IVUS Catheter Procedures, Global, 2022 548
Chart 16‑3: IVUS Procedures by Region, Global, 2019 – 2029 556
Chart 16‑4: Leading Competitors, IVUS Catheter Market, Global, 2022 576
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Figure List:
List of Figures
Figure 1‑1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2) 4
Figure 1‑2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2) 4
Figure 1‑3: Companies Researched in This Report (1 of 2) 5
Figure 1‑4: Companies Researched in This Report (2 of 2) 6
Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment,  Global (1 of 2) 7
Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment,  Global (2 of 2) 8
Figure 1‑7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2) 9
Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2) 10
Figure 1‑9: Interventional Cardiology Device Procedures Covered 11
Figure 1‑10: Interventional Cardiology Device Markets Covered 12
Figure 1‑11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2) 13
Figure 1‑12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2) 14
Figure 1‑13: Version History 15
Figure 2‑1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) 34
Figure 2‑2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) 35
Figure 2‑3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) 36
Figure 2‑4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) 37
Figure 2‑5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) 38
Figure 2‑6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) 39
Figure 4‑1: Coronary Stents by Company 50
Figure 4‑2: Coronary Balloon Catheters by Company 52
Figure 4‑3: Interventional Coronary Catheters by Company 54
Figure 4‑4: Interventional Coronary Guidewires by Company 56
Figure 4‑5: Coronary Embolic Protection Devices by Company 58
Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company 60
Figure 4‑7: Coronary Introducer Sheaths by Company (1 of 2) 62
Figure 4‑8: Coronary Introducer Sheaths by Company (2 of 2) 63
Figure 4‑9: Coronary Vascular Closure Devices by Company 65
Figure 4‑10: Diagnostic Coronary Catheters & Guidewires by Company 67
Figure 4‑11: Coronary Intravascular Ultrasound Devices by Company 69
Figure 4‑12: Coronary Optical Coherence Tomography by Company 71
Figure 4‑13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System 72
Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm 72
Figure 4‑15: Class 2 Device Recall Cordis Precise Nitinol Stent System 72
Figure 4‑16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System 73
Figure 4‑17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System 73
Figure 4‑18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter 74
Figure 4‑19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter 74
Figure 4‑20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters 75
Figure 4‑21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter 75
Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter 75
Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter 75
Figure 4‑24: Class 2 Device Recall MAMBA Flex 135 Microcatheter 76
Figure 4‑25: Class 2 Device Recall MAMBA Microcatheter 76
Figure 4‑26: Class 2 Device Recall Guidezilla II Guide Extension Catheter 76
Figure 4‑27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER 77
Figure 4‑28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter 77
Figure 4‑29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters 77
Figure 4‑30: Class 1 Device Recall 6F Taiga Guiding Catheter 78
Figure 4‑31: Class 2 Device Recall Destination Guiding Sheath 78
Figure 4‑32: Class 2 Device Recall Stingray" Guidewire 79
Figure 4‑33: Class 1 Device Recall TurboHawk Plus 80
Figure 4‑34: Class 1 Device Recall HawkOne 80
Figure 4‑35: Class 2 Device Recall Boston Scientific ROTAPRO 80
Figure 4‑36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM 80
Figure 4‑37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER 81
Figure 4‑38: Class 2 Device Recall 81
Figure 4‑39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification 81
Figure 4‑40: Class 2 Device Recall Prelude Short Sheath Introducer 82
Figure 4‑41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer 82
Figure 4‑42: Class 2 Device Recall Avanti Catheter Sheath Introducer 82
Figure 4‑43: Class 1 Device Recall Flexor CheckFlo Introducer 82
Figure 4‑44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS 83
Figure 4‑45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER 83
Figure 4‑46: Class 1 Device Recall Portico Solo ReCollapsible Access System 83
Figure 4‑47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System 83
Figure 4‑48: Class 2 Device Recall Microintroducer Kit 84
Figure 4‑49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices 85
Figure 4‑50: Class 2 Device Recall AngioSeal Evolution 85
Figure 4‑51: Class 1 Device Recall Imager II 5F Angiographic Catheter 86
Figure 4‑52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter 87
Figure 4‑53: Class 2 Device Recall iLab Polaris MultiModality Guidance System 87
Figure 4‑54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN) 89
Figure 4‑55: RESOLUTE ONYX China Single Arm Study 89
Figure 4‑56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48) 90
Figure 4‑57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System 90
Figure 4‑58: PROMUS PREMIER™ China Post-Approval Study 91
Figure 4‑59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) 91
Figure 4‑60: China Resolute Integrity 34/38 mm Study 92
Figure 4‑61: ILUMIEN IV: OPTIMAL PCI 92
Figure 4‑62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) 93
Figure 4‑63: RESOLUTE ONYX Post-Approval Study (ONYX PAS) 93
Figure 4‑64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V) 94
Figure 4‑65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48) 94
Figure 4‑66: Sirolimus DEB in Coronary Bifurcation Lesions 95
Figure 4‑67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) 95
Figure 4‑68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF) 96
Figure 4‑69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST) 96
Figure 4‑70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater 97
Figure 4‑71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I) 97
Figure 4‑72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease 97
Figure 4‑73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases 98
Figure 4‑74: FIRE AND ICE II Trial Pilot 99
Figure 4‑75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD) 99
Figure 4‑76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First) 100
Figure 4‑77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI) 101
Figure 4‑78: Pressure Guidewire Comparison 101
Figure 4‑79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2) 102
Figure 4‑80: transShield Embolic Protection System Feasibility Study 102
Figure 4‑81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation 103
Figure 4‑82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis 103
Figure 4‑83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s 104
Figure 4‑84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT) 104
Figure 4‑85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT) 105
Figure 4‑86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD) 105
Figure 4‑87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial 106
Figure 4‑88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF) 106
Figure 4‑89: Application of Vascular Closure Device in Transvenous Cardiac Intervention 107
Figure 4‑90: Comparison of Different Vascular Closure Device in TAVI 107
Figure 4‑91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease 108
Figure 4‑92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE) 108
Figure 4‑93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial 109
Figure 4‑94: Vascular Closure Device in Transcatheter Aortic Valve Replacement 109
Figure 4‑95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) 110
Figure 4‑96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES) 110
Figure 4‑97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System 111
Figure 4‑98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) 111
Figure 4‑99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER) 112
Figure 4‑100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS) 112
Figure 4‑101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP) 113
Figure 4‑102: The OPTIMAL Randomized Controlled Trial 113
Figure 4‑103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite) 114
Figure 4‑104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES) 114
Figure 4‑105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS) 115
Figure 4‑106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB) 116
Figure 4‑107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography 116
Figure 4‑108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM) 117
Figure 4‑109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging 117
Figure 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) 123
Figure 5‑2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) 124
Figure 5‑3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M) 128
Figure 5‑4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2) 139
Figure 5‑5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2) 140
Figure 5‑6: SWOT Analysis, Abbott (1 of 2) 155
Figure 5‑7: SWOT Analysis, Abbott (2 of 2) 156
Figure 5‑8: SWOT Analysis, Asahi Intecc 157
Figure 5‑9: SWOT Analysis, Boston Scientific 158
Figure 5‑10: SWOT Analysis, Cordis 159
Figure 5‑11: SWOT Analysis, Cook Medical 160
Figure 5‑12: SWOT Analysis, Medtronic 161
Figure 5‑13: SWOT Analysis, Penumbra 162
Figure 5‑14: SWOT Analysis, Philips 163
Figure 5‑15: SWOT Analysis, Teleflex 164
Figure 5‑16: SWOT Analysis, Terumo 165
Figure 6‑1: Coronary Stent Procedures Covered 169
Figure 6‑2: Coronary Stent Markets Covered 170
Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2) 171
Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2) 172
Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 176
Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 178
Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 179
Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 180
Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 181
Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 182
Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 183
Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 184
Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 185
Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 186
Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 187
Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 188
Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M) 190
Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M) 192
Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029 194
Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029 195
Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$) 196
Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M) 197
Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029 198
Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029 199
Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$) 200
Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M) 201
Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029 202
Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 203
Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$) 204
Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M) 205
Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022 211
Figure 7‑1: Coronary Balloon Catheter Procedures Covered 217
Figure 7‑2: Coronary Balloon Catheter Markets Covered 218
Figure 7‑3: Coronary Balloon Catheter Regions Covered, Global (1 of 2) 219
Figure 7‑4: Coronary Balloon Catheter Regions Covered, Global (2 of 2) 220
Figure 7‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 224
Figure 7‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 226
Figure 7‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 227
Figure 7‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 228
Figure 7‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 229
Figure 7‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 230
Figure 7‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 231
Figure 7‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 232
Figure 7‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 233
Figure 7‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 234
Figure 7‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 235
Figure 7‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 236
Figure 7‑17: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 (US$M) 238
Figure 7‑18: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 (US$M) 240
Figure 7‑19: Total Coronary Balloon Catheter Market, Global, 2019 – 2029 242
Figure 7‑20: Units Sold by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 243
Figure 7‑21: Average Selling Price by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$) 244
Figure 7‑22: Market Value by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$M) 245
Figure 7‑23: PTCA Balloon Catheter Market, Global, 2019 – 2029 246
Figure 7‑24: Units Sold by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 247
Figure 7‑25: Average Selling Price by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$) 248
Figure 7‑26: Market Value by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$M) 249
Figure 7‑27: Specialty Balloon Catheter Market, Global, 2019 – 2029 250
Figure 7‑28: Units Sold by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 251
Figure 7‑29: Average Selling Price by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$) 252
Figure 7‑30: Market Value by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$M) 253
Figure 7‑31: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 258
Figure 8‑1: Interventional Coronary Catheter Procedures Covered 263
Figure 8‑2: Interventional Coronary Catheter Regions Covered, Global (1 of 2) 264
Figure 8‑3: Interventional Coronary Catheter Regions Covered, Global (2 of 2) 265
Figure 8‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 268
Figure 8‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 270
Figure 8‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 271
Figure 8‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 272
Figure 8‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 273
Figure 8‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 274
Figure 8‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 275
Figure 8‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 276
Figure 8‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 277
Figure 8‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 278
Figure 8‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 279
Figure 8‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 280
Figure 8‑16: Interventional Coronary Catheter Market, Global, 2019 – 2029 281
Figure 8‑17: Units Sold by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 282
Figure 8‑18: Average Selling Price by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$) 283
Figure 8‑19: Market Value by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$M) 284
Figure 8‑20: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 289
Figure 9‑1: Interventional Coronary Guidewire Procedures Covered 294
Figure 9‑2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2) 295
Figure 9‑3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2) 296
Figure 9‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 299
Figure 9‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 301
Figure 9‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 302
Figure 9‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 303
Figure 9‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 304
Figure 9‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 305
Figure 9‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 306
Figure 9‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 307
Figure 9‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 308
Figure 9‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 309
Figure 9‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 310
Figure 9‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 311
Figure 9‑16: Interventional Coronary Guidewire Market, Global, 2019 – 2029 312
Figure 9‑17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 313
Figure 9‑18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$) 314
Figure 9‑19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$M) 315
Figure 9‑20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 320
Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2) 326
Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2) 327
Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029 330
Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 331
Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$) 332
Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M) 333
Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 337
Figure 11‑1: Atherectomy and IVL Device Procedures Covered 343
Figure 11‑2: Atherectomy and IVL Device Regions Covered, Global (1 of 2) 344
Figure 11‑3: Atherectomy and IVL Device Regions Covered, Global (2 of 2) 345
Figure 11‑4: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 348
Figure 11‑5: Coronary Atherectomy and IVL Procedures by Country, North America, 2019 – 2029 350
Figure 11‑6: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 351
Figure 11‑7: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 352
Figure 11‑8: Coronary Atherectomy and IVL Procedures by Country, Western Europe, 2019 – 2029 353
Figure 11‑9: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 354
Figure 11‑10: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 355
Figure 11‑11: Coronary Atherectomy and IVL Procedures by Country, Middle East, 2019 – 2029 356
Figure 11‑12: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 357
Figure 11‑13: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 358
Figure 11‑14: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 359
Figure 11‑15: Coronary Atherectomy and IVL Procedures by Country, Africa, 2019 – 2029 360
Figure 11‑16: Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 361
Figure 11‑17: Units Sold by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 362
Figure 11‑18: Average Selling Price by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$) 363
Figure 11‑19: Market Value by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$M) 364
Figure 11‑20: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 368
Figure 12‑1: Coronary Introducer Sheath Procedures Covered 374
Figure 12‑2: Coronary Introducer Sheath Regions Covered, Global (1 of 2) 375
Figure 12‑3: Coronary Introducer Sheath Regions Covered, Global (2 of 2) 376
Figure 12‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 380
Figure 12‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 382
Figure 12‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 383
Figure 12‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 384
Figure 12‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 385
Figure 12‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 386
Figure 12‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 387
Figure 12‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 388
Figure 12‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 389
Figure 12‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 390
Figure 12‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 391
Figure 12‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 392
Figure 12‑16: Coronary Introducer Sheath Market, Global, 2019 – 2029 393
Figure 12‑17: Units Sold by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 394
Figure 12‑18: Average Selling Price by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$) 395
Figure 12‑19: Market Value by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$M) 396
Figure 12‑20: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 402
Figure 13‑1: Coronary Vascular Closure Device Procedures Covered 407
Figure 13‑2: Coronary Vascular Closure Device Markets Covered 408
Figure 13‑3: Coronary Vascular Closure Device Regions Covered, Global (1 of 2) 409
Figure 13‑4: Coronary Vascular Closure Device Regions Covered, Global (2 of 2) 410
Figure 13‑5: Total Catheterization Procedures by Region, Global, 2019 – 2029 413
Figure 13‑6: Catheterization Procedures by Country, North America, 2019 – 2029 415
Figure 13‑7: Catheterization Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 416
Figure 13‑8: Catheterization Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 417
Figure 13‑9: Catheterization Procedures by Country, Western Europe, 2019 – 2029 418
Figure 13‑10: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 419
Figure 13‑11: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 420
Figure 13‑12: Catheterization Procedures by Country, Middle East, 2019 – 2029 421
Figure 13‑13: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 422
Figure 13‑14: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 423
Figure 13‑15: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 424
Figure 13‑16: Catheterization Procedures by Country, Africa, 2019 – 2029 425
Figure 13‑17: Coronary Vascular Closure Device Market by Segment,  Global, 2019 – 2029 (US$M) 427
Figure 13‑18: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 (US$M) 429
Figure 13‑19: Coronary Vascular Closure Device Market, Global, 2019 – 2029 432
Figure 13‑20: Units Sold by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 433
Figure 13‑21: Average Selling Price by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$) 434
Figure 13‑22: Market Value by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$M) 435
Figure 13‑23: Invasive VCD Market, Global, 2019 – 2029 436
Figure 13‑24: Units Sold by Region, Invasive VCD Market, Global, 2019 – 2029 437
Figure 13‑25: Average Selling Price by Region, Invasive VCD Market, Global, 2019 – 2029 (US$) 438
Figure 13‑26: Market Value by Region, Invasive VCD Market, Global, 2019 – 2029 (US$M) 439
Figure 13‑27: Non-Invasive VCD Market, Global, 2019 – 2029 440
Figure 13‑28: Units Sold by Region, Non-Invasive VCD Market, Global, 2019 – 2029 441
Figure 13‑29: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$) 442
Figure 13‑30: Market Value by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$M) 443
Figure 13‑31: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 448
Figure 14‑1: Diagnostic Catheter and Guidewire Procedures Covered 454
Figure 14‑2: Diagnostic Catheter and Guidewire Markets Covered 455
Figure 14‑3: Diagnostic Catheter and Guidewire Regions Covered, Global (1 of 2) 456
Figure 14‑4: Diagnostic Catheter and Guidewire Regions Covered, Global (2 of 2) 457
Figure 14‑5: Total Diagnostic Catheter and Guidewire Procedures by Segment,  Global, 2019 – 2029 459
Figure 14‑6: Angiography Procedures by Region, Global, 2019 – 2029 461
Figure 14‑7: Angiography Procedures by Country, North America, 2019 – 2029 463
Figure 14‑8: Angiography Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 464
Figure 14‑9: Angiography Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 465
Figure 14‑10: Angiography Procedures by Country, Western Europe, 2019 – 2029 466
Figure 14‑11: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 467
Figure 14‑12: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 468
Figure 14‑13: Angiography Procedures by Country, Middle East, 2019 – 2029 469
Figure 14‑14: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 470
Figure 14‑15: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 471
Figure 14‑16: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 472
Figure 14‑17: Angiography Procedures by Country, Africa, 2019 – 2029 473
Figure 14‑18: FFR Guidewire Procedures by Region, Global, 2019 – 2029 475
Figure 14‑19: FFR Guidewire Procedures by Country, North America, 2019 – 2029 477
Figure 14‑20: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 478
Figure 14‑21: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 479
Figure 14‑22: FFR Guidewire Procedures by Country, Western Europe, 2019 – 2029 480
Figure 14‑23: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 481
Figure 14‑24: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 482
Figure 14‑25: FFR Guidewire Procedures by Country, Middle East, 2019 – 2029 483
Figure 14‑26: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 484
Figure 14‑27 FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 485
Figure 14‑28: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 486
Figure 14‑29: FFR Guidewire Procedures by Country, Africa, 2019 – 2029 487
Figure 14‑30: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 (US$M) 489
Figure 14‑31: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 (US$M) 491
Figure 14‑32: Total Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 493
Figure 14‑33: Units Sold by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 494
Figure 14‑34: Average Selling Price by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$) 495
Figure 14‑35: Market Value by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$M) 496
Figure 14‑36: Interventional Diagnostic Catheter Market, Global, 2019 – 2029 497
Figure 14‑37: Units Sold by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 498
Figure 14‑38: Average Selling Price by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$) 499
Figure 14‑39: Market Value by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$M) 500
Figure 14‑40: Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 501
Figure 14‑41: Units Sold by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 502
Figure 14‑42: Average Selling Price by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$) 503
Figure 14‑43: Market Value by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$M) 504
Figure 14‑44: FFR Guidewire Market, Global, 2019 – 2029 505
Figure 14‑45: Units Sold by Region, FFR Guidewire Market, Global, 2019 – 2029 506
Figure 14‑46: Average Selling Price by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$) 507
Figure 14‑47: Market Value by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$M) 508
Figure 14‑48: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 514
Figure 15‑1: OCT Catheter Procedures Covered 519
Figure 15‑2: OCT Catheter Regions Covered, Global (1 of 2) 520
Figure 15‑3: OCT Catheter Regions Covered, Global (2 of 2) 521
Figure 15‑4: OCT Procedures by Region, Global, 2019 – 2029 525
Figure 15‑5: OCT Procedures by Country, North America, 2019 – 2029 527
Figure 15‑6: OCT Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 528
Figure 15‑7: OCT Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 529
Figure 15‑8: OCT Procedures by Country, Western Europe, 2019 – 2029 530
Figure 15‑9: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 531
Figure 15‑10: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 532
Figure 15‑11: OCT Procedures by Country, Middle East, 2019 – 2029 533
Figure 15‑12: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 534
Figure 15‑13: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 535
Figure 15‑14: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 536
Figure 15‑15: OCT Procedures by Country, Africa, 2019 – 2029 537
Figure 15‑16: OCT Catheter Market, Global, 2019 – 2029 538
Figure 15‑17: Units Sold by Region, OCT Catheter Market, Global, 2019 – 2029 539
Figure 15‑18: Average Selling Price by Region, OCT Catheter Market, Global, 2019 – 2029 (US$) 540
Figure 15‑19: Market Value by Region, OCT Catheter Market, Global, 2019 – 2029 (US$M) 541
Figure 15‑20: Leading Competitors, OCT Catheter Market, Global, 2022 545
Figure 16‑1: IVUS Catheter Procedures Covered 550
Figure 16‑2: IVUS Catheter Regions Covered, Global (1 of 2) 551
Figure 16‑3: IVUS Catheter Regions Covered, Global (2 of 2) 552
Figure 16‑4: IVUS Procedures by Region, Global, 2019 – 2029 555
Figure 16‑5: IVUS Procedures by Country, North America, 2019 – 2029 557
Figure 16‑6: IVUS Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 558
Figure 16‑7: IVUS Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 559
Figure 16‑8: IVUS Procedures by Country, Western Europe, 2019 – 2029 560
Figure 16‑9: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 561
Figure 16‑10: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 562
Figure 16‑11: IVUS Procedures by Country, Middle East, 2019 – 2029 563
Figure 16‑12: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 564
Figure 16‑13: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 565
Figure 16‑14: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 566
Figure 16‑15: IVUS Procedures by Country, Africa, 2019 – 2029 567
Figure 16‑16: IVUS Catheter Market, Global, 2019 – 2029 568
Figure 16‑17: Units Sold by Region, IVUS Catheter Market, Global, 2019 – 2029 569
Figure 16‑18: Average Selling Price by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$) 570
Figure 16‑19: Market Value by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$M) 571
Figure 16‑20: Leading Competitors, IVUS Catheter Market, Global, 2022 575

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

iData’s global interventional cardiology MedSuite covers 11 markets including the coronary stent and introducer sheath markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

  • 2023
  • 10 Years
  • Global
  • 577
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library